00348.HK
China Healthwise Holdings Limited
HKSE · Healthcare · Medical - Pharmaceuticals · HK
HKD 0.07
+0.00%Year over year
Reported trailing growth
- Revenue
- -0.5%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- -100.0%
- Operating cash flow
- -39.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -11.2%
- EBITDA
- +38.5%
- EBIT
- +38.1%
- Net income
- +93.5%
- EPS
- +93.5%
- Free cash flow
- -54.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026